WHO seeks 'additional clarifications' from Bharat Biotech for Covaxin's emergency use approval
The World Health Organisation's technical advisory group will now meet on November 3 for a final assessment.
Oct 27, 2021, 07:48 AM IST
Emergency use listing for Covaxin: WHO's technical advisory group to decide today
It’s expected that the technical advisory group will most likely consider granting the EUL for Covaxin in today's meeting. A top WHO official had earlier said that the process of thoroughly evaluating a vaccine for use and recommending it sometimes takes a longer time.
Oct 26, 2021, 06:48 AM IST
Bharat Biotech chairman lauds govt on achieving 100 cr COVID vaccine doses; terms it significant feat
"Credit goes to country`s scientists and also government system that delivered vaccine to the last mile of delivery. We proved to the world that Indian industry can do it," said Chairman and Managing Director of Bharat Biotech Dr Krishna Ella.
Oct 22, 2021, 07:01 AM IST
‘Cannot cut corners' in approving Covaxin, expecting more info from Bharat Biotech: WHO
WHO said, "we are aware that many people are waiting for WHO's recommendation for Covaxin to be included in the #COVID-19 Emergency Use Listing, but we cannot cut corners - before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective."
Oct 18, 2021, 23:24 PM IST
WHO group to meet on October 26 to consider Covaxin's emergency listing
"The technical advisory group will meet on Oct 26th to consider EUL for #Covaxin. @WHO has been working closely with @BharatBiotech to complete the dossier. Our goal is to have a broad portfolio of vaccines approved for emergency use and to expand access to populations everywhere," WHO Chief Scientist said in a tweet.
Oct 17, 2021, 23:40 PM IST
Covaxin's approval for children aged 2-18 yrs under experts' opinion, evaluation: Sources
Bharat Biotech in an official statement had said they are waiting for further approvals from drug regulators.
Oct 14, 2021, 20:54 PM IST
WHO's emergency use nod to Covaxin: Expert panel to decide today
Documents detailing the WHO expert committee's agenda for the meeting show that it will discuss the assessment status of pending applications for vaccine candidates, including Covaxin.
Oct 05, 2021, 09:01 AM IST
India to make a record of 100 crore vaccinations
We are breaking our own record in the Corona Vaccination case, know how close we are to the record 100 crore figure.
Oct 03, 2021, 17:00 PM IST
WHO's emergency use nod for Covaxin most likely in October
The EUA is important because without it Covaxin will not be accepted by most countries. WHO’s Strategic Advisory Group of Expert on Immunization (SAGE) is set to meet on October 5 to take a call on EUA to Covaxin.
Sep 30, 2021, 09:08 AM IST
Actively working with WHO, emergency use authorisation for Covaxin expected soon: Bharat Biotech
The emergency use authorisation (EUA) is important because without it Covaxin will not be accepted by most countries.
Sep 28, 2021, 17:04 PM IST
WHO further delays emergency use authorisation for Covaxin over technical issues: Report
Without EUA, Covaxin will not be considered an accepted vaccine by most countries around the world. the WHO's queries for Bharat Biotech comes despite the Hyderabad-based drug maker asserting that it has submitted all data required for clearance.
Sep 28, 2021, 06:39 AM IST
WHO's emergency use authorization to Covaxin expected soon: MoS Health Dr Bharati Pravin Pawar
“WHO's emergency use authorization to Covaxin is expected soon,” Dr Bharati Pravin Pawar, MoS, Health, was quoted as saying by news agency ANI.
Sep 24, 2021, 19:31 PM IST
WHO emergency use authorisation to Bharat Biotech’s Covaxin delayed till October 5
According to WHO, the Strategic Advisory Group of Experts on Immunization (SAGE) will be meeting on October 5 to grant emergency use authorisation (EUA) to Bharat Biotech’s Covaxin.
Sep 18, 2021, 06:31 AM IST
Delhi AIIMS to begin Phase 2/3 clinical trials of Bharat Biotech's nasal COVID-19 vaccine soon: Sources
Sources said that the country`s premier hospital and research center will be starting trials within a couple of weeks and an application has been put to seek the mandatory permission of the AIIMS Ethics Committee.
Sep 09, 2021, 07:09 AM IST
Breaking News: Bharat Biotech rolls out first commercial batch of Covaxin from new plant
Union Health Minister Mansukh Mandaviya released the first commercial batch of Covaxin from Bharat Biotech's new plant in Ankleshwar, Gujarat.
Aug 29, 2021, 15:52 PM IST
India's first nasal vaccine for COVID soon? Bharat Biotech's intranasal vaccine gets nod for Phase 2/3 trials
The DBT apprised that Phase 1 clinical trial of the nasal vaccine candidate, BBV154, has been completed in age groups ranging from 18 to 60 years.
Aug 13, 2021, 19:44 PM IST
Indian Immunologicals Ltd produces Covaxin drug substance in record time
The output of the Covaxin drug substance will be 3 to 4 million a month and from Dec will increase to 10 million a month.
Aug 13, 2021, 17:48 PM IST
Every batch of Covaxin subjected to more than 200 quality control tests: Bharat Biotech amid quality concerns
The statement came after reports that test batches of Covaxin from the Bengaluru plant were not satisfactory and got rejected leading to delayed production.
Aug 05, 2021, 23:16 PM IST
Another milestone! Bharat Biotech’s Covaxin receives GMP compliance certificate from Hungary
Vaccine maker Bharat Biotech announced on Thursday that it`s COVID-19 vaccine, Covaxin, has received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities.
Aug 05, 2021, 14:45 PM IST
Bharat Biotech terminates MoU with Brazilian partners after graft allegations
The termination of the MoU came after the deal with the Brazilian government for supply of 20 million doses of the vaccinelanded in controversy and attracted investigation by authorities in that country.
Jul 23, 2021, 21:33 PM IST
